Skip to main content
. 2021 Feb 2;45(4):206–214. doi: 10.4103/jmp.JMP_45_20

Table 4.

The nominal maximum dose D1% to various serial organs and mean dose Dmean to cochlea from the competing treatment plans and their worst case increase D1% and Dmean. Units are Gy RBE for proton and Gy for photon plans

Structure Indices Techniques

SFO MFO HB-MFO IMRT RB-IMRT
Brain stem NM-D1% 53.64±6.74 53.68±2.84 50.38±2.32 52.71±3.08 51.61±2.08
WI-D1% 63.11±3.64 66.97±2.82 63.55±2.33 67.78±3.14 64.32±2.14
Chiasm NM-D1% 52.84±1.72 52.81±1.38 50.09±1.81 50.10±3.65 50.10±1.80
WI-D1% 63.81±3.38 66.20±2.92 63.62±2.40 70.78±4.32 64.12±3.10
Spinal cord NM-D1% 46.65±3.00 47.02±3.70 44.55±2.30 45.52±3.70 45.10±3.10
WI-D1% 59.20±2.46 62.87±1.32 58.69±2.30 65.14±2.52 60.10±1.84
RT-optic nerve NM-D1% 58.14±8.21 54.92±8.50 52.35±2.32 53.09±6.31 52.01±3.30
WI-D1% 66.59±3.34 67.17±5.94 65.60±2.04 69.53±1.62 66.32±3.52
LT-optic nerve NM-D1% 51.22±2.18 51.40±3.70 49.50±1.10 49.15±2.90 50.71±3.10
WI-D1% 63.48±5.20 64.83±1.69 63.20±1.76 69.32±3.03 64.10±1.89
RT-temporal lob NM-D1% 62.88±4.71 61.67±3.43 57.26±3.53 62.56±3.85 61.54±2.81
WI-D1% 67.54±2.80 68.77±3.14 65.76±3.58 70.06±4.18 67.14±2.90
LT-temporal lob NM-D1% 6349±3.93 62.53±5.86 57.39±4.44 63.93±4.40 62.13±3.30
WI-D1% 68.03±2.72 68.84±4.26 65.60±3.74 71.47±4.39 66.60±3.39
RT-cochlea NM-Dmean 36.63±8.19 34.47±7.25 27.45±3.08 37.27±8.34 33.12±4.89
WI-Dmean 39.66±10.35 41.76±11.45 35.06±11.12 44.69±8.24 40.89±5.32
LT cochlea NM-Dmean 31.77±17.3 30.97±17.40 28.84±18.8 34.74±15.10 32.12±14.35
WI-Dmean 42.16±5.23 47.74±8.39 41.40±4.43 48.68±5.20 45.32±6.20

SFO: Single field uniform optimization, MFO: Multi field optimization, HB-MFO: Hybrid-multi field optimization, IMRT: Intensity modulated radiotherapy, RB-IMRT: Robustly optimized-intensity modulated radiotherapy, NM-D: Nominal maximum dose, WI-D: Worst case increase dose